Salivary protein biomarkers for head and neck cancer

References

• Huang SH, O’Sullivan B. Overview of the 8th Edition TNM classification for head and neck cancer. Curr Treat Options Oncol. 2017 Jul;18(7):40. PubMed PMID: 28555375; eng.
   PubMed Web of Science ®Google Scholar
• Lydiatt WM, Patel SG, O’Sullivan B, et al. Head and neck cancers-major changes in the American joint committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017 Mar;67(2):122–137. PubMed PMID: 28128848; eng.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394–424. PubMed PMID: 30207593; eng.
   PubMed Web of Science ®Google Scholar
• Cohen N, Fedewa S, Chen AY. Epidemiology and demographics of the head and neck cancer population. Oral Maxillofac Surg Clin North Am. 2018 Nov;30(4):381–395. PubMed PMID: 30078696; eng.
   PubMed Web of Science ®Google Scholar
• Simard EP, Torre LA, Jemal A. International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site. Oral Oncol. 2014 2014 May 01;50(5):387–403.
   PubMed Web of Science ®Google Scholar
• Rettig EM, D’Souza G. Epidemiology of head and neck cancer. Surg Oncol Clin N Am. 2015 Jul;24(3):379–396. PubMed PMID: 25979389; eng.
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Hisamatsu K, Suzui N, et al. A review of HPV-related head and neck cancer. J Clin Med. 2018 Aug 27;7(9):241. PubMed PMID: 30150513; PubMed Central PMCID: PMCPMC6162868. eng.
   Web of Science ®Google Scholar
• Ha PK, Califano JA. The molecular biology of mucosal field cancerization of the head and neck. Crit Rev Oral Biol Med. 2003 2003 Sep 01;14(5):363–369.
   PubMedGoogle Scholar
• Schmidt H, Kulasinghe A, Perry C, et al. A liquid biopsy for head and neck cancers. Expert Rev Mol Diagn. 2016;16(2):165–172. PubMed PMID: 26631411; eng.
   PubMed Web of Science ®Google Scholar
• Pfaffe T, Cooper-White J, Beyerlein P, et al. Diagnostic potential of saliva: current state and future applications. Clin Chem. 2011 May;57(5):675–687. PubMed PMID: 21383043.
   PubMed Web of Science ®Google Scholar
• Nonaka T, Wong DTW. Saliva-exosomics in cancer: molecular characterization of cancer-derived exosomes in saliva. Enzymes. 2017;42:125–151. PubMed PMID: 29054268; eng.
   PubMedGoogle Scholar
• Arunachalam SR, Tang KD, Punyadeera C. Isolation and quantification of MicroRNAs from human saliva. Methods Mol Biol. 2019;2054:105–114. PubMed PMID: 31482450; eng.
   PubMedGoogle Scholar
• Lim Y, Fukuma N, Totsika M, et al. The performance of an oral microbiome biomarker panel in predicting oral cavity and oropharyngeal cancers. Front Cell Infect Microbiol. 2018;8:267. PubMed PMID: 30123780; PubMed Central PMCID: PMCPMC6085444. eng.
   PubMed Web of Science ®Google Scholar
• Lim Y, Totsika M, Morrison M, et al. Oral microbiome: a new biomarker reservoir for oral and oropharyngeal cancers. Theranostics. 2017;7(17):4313–4321. PubMed PMID: 29158828; PubMed Central PMCID: PMCPMC5695015. eng.
   PubMed Web of Science ®Google Scholar
• Chu HW, Chang KP, Hsu CW, et al. Identification of salivary biomarkers for oral cancer detection with untargeted and targeted quantitative proteomics approaches. Mol Cell Proteomics. 2019 Sep;18(9):1796–1806. PubMed PMID: 31253657; PubMed Central PMCID: PMCPMC6731081. eng.
   PubMed Web of Science ®Google Scholar
• Rajkumar K, Ramya R, Nandhini G, et al. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma. Oral Dis. 2015 Jan;21(1):90–96. PubMed PMID: 24304502; eng.
   PubMed Web of Science ®Google Scholar
• Varun C, Dineshkumar T, Jayant VS, et al. Salivary Her2/neu levels in differentiation of oral premalignant disorders and oral squamous cell carcinomas. Asian Pac J Cancer Prev. 2015;16(14):5773–5777. PubMed PMID: 26320450; eng.
   PubMedGoogle Scholar
• Zheng J, Sun L, Yuan W, et al. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma. J Oral Pathol Med. 2018 Oct;47(9):830–835. PubMed PMID: 30028540; eng.
   PubMed Web of Science ®Google Scholar
• Aziz S, Ahmed SS, Ali A, et al. Salivary immunosuppressive cytokines IL-10 and IL-13 are significantly elevated in oral squamous cell carcinoma patients. Cancer Invest. 2015;33(7):318–328. PubMed PMID: 26046681; eng.
   PubMed Web of Science ®Google Scholar
• Goncalves AS, Arantes DA, Bernardes VF, et al. Immunosuppressive mediators of oral squamous cell carcinoma in tumour samples and saliva. Hum Immunol. 2015 Jan;76(1):52–58. PubMed PMID: 25500427; eng.
   PubMed Web of Science ®Google Scholar
• Lee LT, Wong YK, Hsiao HY, et al. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2018 Jun;47(6):699–707. PubMed PMID: 29174861; eng.
   PubMed Web of Science ®Google Scholar
• Panneer Selvam N, Sadaksharam J. Salivary interleukin-6 in the detection of oral cancer and precancer. Asia Pac J Clin Oncol. 2015 Sep;11(3):236–241. PubMed PMID: 25560781; eng.
   PubMed Web of Science ®Google Scholar
• Polz-Dacewicz M, Strycharz-Dudziak M, Dworzański J, et al. Salivary and serum IL-10, TNF-α, TGF-β, VEGF levels in oropharyngeal squamous cell carcinoma and correlation with HPV and EBV infections. Infect Agent Cancer. 2016;11:45. PubMed PMID: 27547238; eng.
   PubMed Web of Science ®Google Scholar
• Russo N, Bellile E, Murdoch-Kinch CA, et al. Cytokines in saliva increase in head and neck cancer patients after treatment. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Oct;122(4):483–490.e1. PubMed PMID: 27554375; PubMed Central PMCID: PMCPMC5031552. eng.
   PubMed Web of Science ®Google Scholar
• Arduino PG, Menegatti E, Cappello N, et al. Possible role for interleukins as biomarkers for mortality and recurrence in oral cancer. Int J Biol Markers. 2015 May 26;30(2):e262–6. PubMed PMID: 25838055; eng.
   PubMed Web of Science ®Google Scholar
• Sahibzada HA, Khurshid Z, Khan RS, et al. Salivary IL-8, IL-6 and TNF-α as potential diagnostic biomarkers for oral cancer. Diagnostics (Basel). 2017;7(2):21. PubMed PMID: 28397778; eng.
   PubMed Web of Science ®Google Scholar
• Csosz E, Labiscsak P, Kallo G, et al. Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers. PLoS One. 2017;12(5):e0177282. PubMed PMID: 28545132; PubMed Central PMCID: PMCPMC5436697. eng.
   PubMed Web of Science ®Google Scholar
• Scheller J, Garbers C, Rose-John S. Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities. Semin Immunol. 2014 Feb;26(1):2–12. PubMed PMID: 24325804; eng.
   PubMed Web of Science ®Google Scholar
• Kumari N, Dwarakanath BS, Das A, et al. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol. 2016 Sep;37(9):11553–11572. PubMed PMID: 27260630; eng.
   PubMedGoogle Scholar
• Sato J, Ohuchi M, Wada M, et al. Differences in sequential posttreatment salivary IL-6 levels between patients with and patients without locoregional recurrences of oral squamous cell carcinoma: part III of a cohort study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Dec;120(6):751–60.e2. PubMed PMID: 26548727; eng.
   PubMed Web of Science ®Google Scholar
• Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 2006 Sep;25(3):409–416. PubMed PMID: 16951987; eng.
   PubMed Web of Science ®Google Scholar
• Gleber-Netto FO, Yakob M, Li F, et al. Salivary biomarkers for detection of oral squamous cell carcinoma in a taiwanese population. Clin Cancer Res. 2016 Jul 1;22(13):3340–3347. PubMed PMID: 26847061; PubMed Central PMCID: PMCPMC4930722. eng.
   PubMed Web of Science ®Google Scholar
• Bent R, Moll L, Grabbe S, et al. Interleukin-1 beta-a friend or foe in malignancies? Int J Mol Sci. 2018;19(8):2155. PubMed PMID: 30042333; eng.
   PubMed Web of Science ®Google Scholar
• Mannino MH, Zhu Z, Xiao H, et al. The paradoxical role of IL-10 in immunity and cancer. Cancer Lett. 2015 2015 Oct 28;367(2):103–107.
   PubMed Web of Science ®Google Scholar
• Senbanjo LT, Chellaiah MA. CD44: a multifunctional cell surface adhesion receptor is a regulator of progression and metastasis of cancer cells. Front Cell Dev Biol. 2017;5:18. PubMed PMID: 28326306; PubMed Central PMCID: PMCPMC5339222. eng.
   PubMed Web of Science ®Google Scholar
• Trapasso S, Garozzo A, Belfiore A, et al. Evaluation of the CD44 isoform v-6 (sCD44var, v6) in the saliva of patients with laryngeal carcinoma and its prognostic role. Cancer Biomark. 2016;16(2):275–280. PubMed PMID: 26756618; eng.
   PubMed Web of Science ®Google Scholar
• Lechner S, Pereira L, Reategui E, et al. Acceptability of a rinse screening test for diagnosing head and neck squamous cell carcinoma among black Americans. J Racial Ethn Health Disparities. 2014 Mar 01;2. doi:10.1007/s40615-014-0048-9
   PubMed Web of Science ®Google Scholar
• Pereira LH, Reis IM, Reategui EP, et al. Risk stratification system for oral cancer screening. Cancer Prev Res (Phila). 2016 Jun;9(6):445–455. PubMed PMID: 27020654; PubMed Central PMCID: PMCPMC5086457. eng.
   PubMed Web of Science ®Google Scholar
• Seyedmajidi S, Seyedmajidi M, Foroughi R, et al. Comparison of salivary and serum soluble CD44 levels between patients with oral SCC and healthy controls. Asian Pac J Cancer Prev. 2018;19(11):3059–3063. PubMed PMID: 30485941; eng.
   PubMedGoogle Scholar
• Treeck O, Buechler C, Ortmann O. Chemerin and cancer. Int J Mol Sci. 2019;20(15):3750. PubMed PMID: 31370263; eng.
   PubMed Web of Science ®Google Scholar
• Ghallab NA, Shaker OG. Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions. Clin Oral Investig. 2017 Apr;21(3):937–947. PubMed PMID: 27161218; eng.
   PubMed Web of Science ®Google Scholar
• Huang H. Matrix metalloproteinase-9 (MMP-9) as a cancer biomarker and MMP-9 biosensors: recent advances. Sensors (Basel). 2018 Sep 27;18(10):3249. PubMed PMID: 30262739; PubMed Central PMCID: PMCPMC6211011. eng.
   Web of Science ®Google Scholar
• Malhotra R, Urs AB, Chakravarti A, et al. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma. Tumour Biol. 2016 Jul;37(7):9263–9271. PubMed PMID: 26779624; eng.
   PubMedGoogle Scholar
• Patel S, Metgud R. Estimation of salivary lactate dehydrogenase in oral leukoplakia and oral squamous cell carcinoma: a biochemical study. J Cancer Res Ther. 2015 Jan-Mar;11(1):119–123. PubMed PMID: 25879348; eng.
   PubMed Web of Science ®Google Scholar
• Rao K, Babu SG, Shetty UA, et al. Serum and salivary lactate dehydrogenase levels as biomarkers of tissue damage among cigarette smokers. A biochemical study. Stomatologija. 2017;19(3):91–96. PubMed PMID: 29339672; eng.
   PubMedGoogle Scholar
• Mafessoni TP, Mazur CE, Amenábar JM. Salivary lactate dehydrogenase (LDH) as a tool for early diagnosis of oral cancer in individuals with Fanconi anemia. Med Hypotheses. 2018 2018;119:29–31. PubMed PMID: WOS:000443787300009.
   PubMed Web of Science ®Google Scholar
• Metgud R, Bajaj S. Altered serum and salivary C-reactive protein levels in patients with oral premalignant lesions and oral squamous cell carcinoma. Biotech Histochem. 2016;91(2):96–101. PubMed PMID: 26529498; eng.
   PubMed Web of Science ®Google Scholar
• Li SX, Yang YQ, Jin LJ, et al. Detection of survivin, carcinoembryonic antigen and ErbB2 level in oral squamous cell carcinoma patients. Cancer Biomark. 2016;17(4):377–382. PubMed PMID: 27662323; eng.
   PubMed Web of Science ®Google Scholar
• Heawchaiyaphum C, Pientong C, Phusingha P, et al. Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches. J Proteomics. 2018 Feb;20(173):52–61. PubMed PMID: 29199150; eng.
   PubMed Web of Science ®Google Scholar
• Garg R, Shetti AV, Bagewadi AS. Assessment and comparison of salivary survivin biomarker in oral leukoplakia, oral lichen planus, and oral cancer: A comparative study. World J Dent. 2017 Mar 01;8:73–76.
   Google Scholar
• van der Merwe L, Wan Y, Cheong HJ, et al. A pilot study to profile salivary angiogenic factors to detect head and neck cancers. BMC Cancer. 2018 2018 Jul 13;18(1):734.
   PubMedGoogle Scholar